USA Medical Scientist Awarded National Grant

The University of South Alabama (USA) has announced that its scientist Dr. Michael R. Elliott recently received a two-year R21 grant for $431,147 from the National Institute of Allergy and Infectious Diseases. Elliott’s goal is to provide new insights aimed at helping patients with cancer and autoimmune diseases avoid and better treat first infusion reactions. “Antibody-based therapies are among the most powerful tools for treating cancer and autoimmune diseases,” he said. “Yet for some patients, the very first infusion of these therapies can trigger inflammatory reactions ranging from mild discomfort to severe complications.” Elliott is an associate professor in the Department of Microbiology and Immunology at USA’s Frederick P. Whiddon College of Medicine. His research aims to uncover the biological triggers of inflammatory reactions, with a particular focus on the immune cells that drive them. He hopes that, by identifying the underlying mechanisms, these therapies will be made safer and more widely accessible to patients.

Read More

Impact100 Mobile Gives $90,000 In Grants

Impact100 Mobile Gives $90,000 In Grants

Downtown Mobile Alliance Announces Promotions

Downtown Mobile Alliance Announces Promotions

TFI Names Douberly President, COO

TFI Names Douberly President, COO

Outside Chief Legal Earns Six Best Law Firms Regional Rankings

Outside Chief Legal Earns Six Best Law Firms Regional Rankings

Baldwin Health Appoints Bussey To Board Of Trustees

Baldwin Health Appoints Bussey To Board Of Trustees

USA Health Adds Patterson To Expand Neurology, Epilepsy Care

USA Health Adds Patterson To Expand Neurology, Epilepsy Care

Foley Dedicates Activity Center

Foley Dedicates Activity Center

Challenge Testing Adds Meyermann As Business Developer

Challenge Testing Adds Meyermann As Business Developer

White-Spunner Construction Names Burgett VP, Operations

White-Spunner Construction Names Burgett VP, Operations

Subscribe to our weekly newsletter

Sign up here for free to get Bay Business News email newsletter every Friday.

By subscribing, you agree to our User Agreement and Privacy Policy & Cookie Statement.

Something went wrong. Please check your entries and try again.